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Gene therapy is currently being developed for Cystic Fibrosis. While various gene
therapy vectors have been successfully delivered to mouse lungs, gene transfer to
the airway epithelium of humans has proven to be inefﬁcient. Pigs share many
features of lung biology with humans, including anatomy, electrolyte transport, and
immune responses. Recently, a porcine CFTR−/− model has been created and the
neonatal CF pigs displayed a high degree of similarity in electrophysiological and
pathological changes to human neonates with CF (Rogers et al, Science, 2008). The
main objective of this study is to develop a pre-clinical model of vector delivery
for CF gene therapy.
In this study, we used wild-type pigs to investigate the technique of viral vector
delivery, to explore the distribution and expression of foreign genes, and to analyze
the host immune responses to Ad vectors and transgene products. Using an
Aeroprobe catheter under ﬂexible bronchoscopic guidance, we aerosolized 5×1012
particles of HD-K18-LacZ into the left lung. A robust level of reporter expression
was detected by X-gal staining in the left lung, but not the control lung. The
nuclear staining of the transduced cells in bronchial and alveolar epithelia was
characteristic of the expression of the nuclear-targeted beta-galactosidase. More
interestingly, many submucosal gland cells, the major CFTR-expressing cells in
the airway, were transduced. Pigs tolerated the procedure and the vector very well.
These results suggest that highly efﬁcient delivery of HD-Ad vectors to the airway
of large animals can be achieved and will provide important insights into the design
of clinical studies for CF lung gene therapy.
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Papillomavirus (HPV) pseudovirions are artiﬁcial vectors constituted of HPV major
capsid protein (L1) and minor capsid protein (L2) packaged with plasmid coding for
a gene of interest. These safe therapeutic gene delivery systems are able to transduce
a wide range of cells. Nevertheless, they were shown to poorly transduce airway
epithelium cells. In order to circumvent this problem, we inserted 3 different airway
cell ligands in the HPV 16 capsid. Several motifs have been described to confer
lung targeting like P1: THALWHT, P2: RFDSLKV and P3: GHPRQMSHVY. These
peptides were inserted in the DE, EF or FG loop of HPV16 L1. These recombinant
L1 proteins were co-expressed with the HPV16 L2 protein in insect cells using the
corresponding recombinant baculoviruses. The capacity of the virus-like particles
obtained to transfer the luciferase gene was investigated in pulmonary cell (S9 and
IB3−1). Five mutant VLPs were selected and tested for their gene transfer capacity.
An increase in gene transfer by 400 to 500-fold was observed in IB3−1 and S9
cells lines compared to Hela cells, with P1DE and P2DE mutants.
In addition, we identiﬁed by phage display two other motifs (VDRLQQK and
PHPNRAQ). Each motif was inserted in the DE loops of HPV16 L1 and expressed
in insect cells. The ability of the VLPs obtained to transfer gene in airway cells is
currently investigated.
In conclusion, the results indicate that cell tropism of viral vectors can be effectively
reengineered by insertion of short peptide ligands in order to produce improved
vectors for application of gene transfer in human airway epithelial cells.
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Non-invasive bioluminescence imaging permits repeated in-vivo quantiﬁcation of
long-lasting gene transfer in individual experimental animals. A single nasal deliv-
ery of our lentiviral (LV) gene transfer vector revealed unusual dynamic changes
in mouse lung gene expression.
Aim: To monitor the location and persistence of LV luciferase gene transfer in
airways in normal and CF mice.
Methods: Normal (C57Bl/6) and CF (CFTRtm1unc) mice received a nasal bolus
instillation of lysophosphatidylcholine (LPC) or PBS control one hour prior to dos-
ing with a Luciferase LV vector (1.8×1010tu/ml). Bioluminescence was measured
10−15 minutes after intranasal D-luciferin delivery (50 ml, 15mg/ml), at 1 week, 1,
3, 6, 9, 12, 15 and 18 months after vector dosing.
Results: C57Bl/6 mice: LPC pre-treatment produced signiﬁcantly higher luciferase
activity than PBS controls in the nasal airways all time points (p< 0.05, RM
ANOVA). Luciferase activity was also present in the lung in both pre-treatment
groups.
CF transgenic mice: LPC pre-treatment also produced signiﬁcantly higher levels
of luminescence in the nasal airways compared to PBS controls (p< 0.05, RM
ANOVA). In contrast to normal mice, lung luminescence was lost at 6 and 9 months
in PBS pre-treated CF mice. Surprisingly, signiﬁcant levels of luminescence in the
lung returned at the 12 month time point.
Conclusions: Luciferase gene expression was signifcantly improved in mouse
nasal airways using LPC pre-treatment in both strains. The re-emergence of
gene expression in lung many months after a single transfection event suggests
involvement of in situ airway stem/progenitor cell transduction in the murine CF
knockout lung.
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Introduction: While small animal models are useful for studying respiratory
diseases such as CF the complexity of physiological studies is increased dramatically
when imaging live animal airways using synchrotron X-rays. Over the last 5
years we have developed techniques at the Japanese SPring-8 synchrotron to
facilitate accurate and reliable visualisation of mouse airways using high-resolution
2D imaging. We will present our effective approaches and discuss continuing
challenges.
Methods: Images of airway surfaces (1.8mm× 1.2mm, pixel resolution 0.45mm),
were captured from live, Nembutal anaesthetised, intubated and ventilated (SCIREQ
ﬂexiVent) mice using a phase-contrast X-ray imaging (PCXI) setup. Animals were
secured on an imaging board for precise orientation in the X-ray beam. Images
were captured at set intervals or gated to ventilator end-expiratory trigger signals.
Results: Two special challenges were the ﬁxed location and orientation of the
horizontal X-ray beam and minimising the effects of small respiratory, cardiac
and muscle movements that can blur images at such high levels of magniﬁcation.
Rapid tracheal intubation facilitated long term study stability, and additional body/
torso restraint together with respiratory-gated image acquisition minimised image
blurring. This permitted effective time-lapse capture and analysis of airway surface
activity.
Conclusions: Synchrotron PCXI of mouse respiratory systems has special chal-
lenges but continues to evolve. Attention to animal-handling and imaging techniques
will permit continued development of novel, high-resolution, live animal airway
physiology imaging for use in respiratory research.
